Physician profile
Robert Trichter
NPI 1629019468
$2,996.81
in general payments reported to CMS, 2019-2025
11 companies · $304 in 2025
The $304 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $772 · 2020: $59.74 · 2021: $275 · 2022: $86.42 · 2023: $609 · 2024: $890 · 2025: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,803.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,803.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $691.98 | 2019-2025 | Aristada, Lybalvi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $665.14 | 2021-2025 | Caplyta |
| Janssen Pharmaceuticals, INC | $582.61 | 2019-2024 | Invega Sustenna, Invega Trinza |
| Neurocrine Biosciences, INC. | $367.14 | 2019-2025 | |
| Vanda Pharmaceuticals INC. | $215.85 | 2024-2025 | Fanapt, Hetlioz |
| Sunovion Pharmaceuticals INC. | $152.53 | 2019-2021 | |
| Indivior INC. | $120.76 | 2019-2023 | Perseris |
| Abbvie INC. | $104.61 | 2021-2023 | Vraylar |
| Lundbeck LLC | $53.30 | 2024 | Abilify Maintena |
| Otsuka America Pharmaceutical, INC. | $23.40 | 2025 | Abilify Asimtufii, Abilify Maintena |
| Teva Pharmaceuticals USA, INC. | $19.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Trichter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.